
United States biotech financing data 2015-2020
In 2020, U.S. biotech companies raised some ten billion U.S. dollars of capital through initial public offerings (IPOs), while they received some 14.2 billion U.S. dollars in risk capital. This statistic contains the financing data of U.S. biotech companies from 2015 to 2020, by type.